key: cord-0705534-ho5cq9qz authors: Famularo, Giuseppe title: Stroke after COVID‐19 vaccination date: 2022-03-07 journal: Acta Neurol Scand DOI: 10.1111/ane.13608 sha: 3dbe557843afa19089f9710acbb9fb32f68ceb81 doc_id: 705534 cord_uid: ho5cq9qz nan To the Editor, de Mélo Silva Jr and Lopes suggest a potential association of COVID-19 vaccination with a risk of developing a brain hemorrhage. I report a case of COVID-19 vaccine-associated ischemic stroke. 1 An 87-year-old woman presented with dysarthria, right gaze deviation, and complete left hemiplegia 24 h after receipt of the second dose of the RNA-based COVID-19 vaccine, BNT 162b2. No symptoms or signs of local or systemic reactogenicity occurred within the 21-day window of the first dose. Previous history was remarkable for ischemic heart disease, hypertension, and dyslipidemia that were managed with aspirin, bisoprolol, ezetimibe, and rosuvastatin. Imaging studies showed a large right infarction, a clot sign indicating an occluding wall-adherent thrombus of the right middle cerebral artery, and no significant atherosclerosis or any other abnormalities of the cervical and intracranial vessels. Aortic, cardiac, and paradoxical embolism was ruled out. Blood count, including platelet count, and coagulation profile were normal. Creactive protein was 12 mg/dl (normal <5 mg/dl). Thrombolysis or thrombectomy was not performed, and anti-platelet therapy was changed to clopidogrel. The patient was ultimately discharged to a rehabilitation facility 32 days after admission. At that time, she had left hemiplegia and dysarthria. This woman presented with cerebral thrombosis after receipt of the second shot of the BNT 162b2 vaccine. The timing of the event, with onset of symptoms as early as within 24 h after vaccination, was consistent with a vaccine-related cause. However, the patient was at risk for stroke independently of vaccination because of cardiovascular profile, past medical history, and the presence of comorbidities. Accordingly, scoring on the Naranjo scale was 2, which suggests to consider alternative causes and only a possible relationship between vaccination and the adverse event. Clinicians should be on the lookout for the onset of cerebral thrombosis after COVID-19 vaccination, particularly in patients with severe atherosclerosis. Nonetheless, this is a rare complication that is greatly outweighed by the benefit of vaccination, and the risk of stroke remains higher with COVID-19 itself than with vaccines. None. Author have no conflict of interest. Large hemorrhagic stroke after ChAdOx1 nCoV-19 vaccination: a case report A method for estimating the probability of adverse drug reactions Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination Thrombosis and thrombocytopenia after ChAdOx1 nCoV-19 vaccination Clinical features of vaccineinduced immune thrombocytopenia and thrombosis Myocardial infarction, stroke, and pulmonary embolism after BNT162b2 mRNA COVID-19 vaccine in people aged 75 years and older Repeated cardioembolic stroke after COVID-19 mRNA vaccination: a case report Ischemic stroke after AstraZeneca (Covid-19) vaccination COVID-19 vaccineassociated cerebral venous thrombosis in Germany Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine Adenovirus-vectored COVID-19 vaccine-induced immune thrombosis of carotid artery Acute ischaemic stroke incidence after coronavirus vaccine in Indonesia: case series Inflammation and the link to vascular brain health: timing is brain How to cite this article: Famularo G. Stroke after COVID-19 vaccination